This physician webinar covers the treatment of amyloidosis patients during the COVID-19 pandemic. With guidelines from the International Society of Amyloidosis, high-risk patient considerations, an update on clinical trials, and policy changes, we cover everything HCPs need to know.
Patient Resources
ARC Talks: Managing Amyloidosis during COVID-19 for Physicians
Related Content
-
Understanding Genetics in Hereditary ATTR AmyloidosisLibrary, Patients
Get the latest Amyloidosis news and research from ARC.
Join our newsletter